Innovation Pharmaceuticals Inc (IPIX)

[snayeman]

Serious question to anyone, with only 120 patients needed for this trial, why is there a need to spread it out over multiple sites including overseas! Wouldn’t it be much easier and quicker to focus on just a couple sites given that there is so many patients everywhere!